Adimab Lands New Round
Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3bee0b16-f12d-42f3-aa1d-cbed19dc16c5&Preview=1
Date
10/1/2009
Company Name
Adimab
Mailing Address
16 Cavendish Court Lebanon, NH 03766
Company Description
Adimab–which stands for Antibody Discovery Maturation Biomanufacturing–is developing a platform that’s deliberately engineered to minimize and potentially eliminate third party royalties, offering a one-stop-service-shop to a select few Big Pharma partners.
Website
http://www.adimab.com
Transaction Type
Venture Equity
Transaction Amount
Undisclosed
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed.
M&A Terms
Venture Investor
Google, Inc.
Venture Investor
Polaris Venture Partners
Venture Investor
SV Life Sciences
Venture Investor
OrbiMed
Venture Investor
Borealis Ventures
Add Your Thoughts
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter .